Atlas Trials

Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

Clinical trial NCT03301467 · COMPLETED

Trial details

NCT number
NCT03301467
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
C3 Glomerulopathy (C3G)
Start date
2017-09-29
Primary completion
2021-03-03
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.